CNS Lymphoma research at ASCO24: Dana-Farber’s Lakshmi Nayak, MD, details findings of a pilot study showing a CAR T-cell therapy has shown promise and is safe and well-tolerated in treating patients with relapsed, treatment-resistant CNS lymphoma.
Press release: https://shorturl.at/xcxN5 Video published 6/7/2024
What you need to know about GIVETAXFREE.ORG
Share
givetaxfree.org
CNS Lymphoma: Lakshmi Nayak, MD | Dana-Farber Cancer Institute [Video]
Categories
FAQs About GiveTaxFree Answered! PART II
Share
givetaxfree.org
![Early ctDNA Molecular Response Enhanced Through Integrated Analyses of Cell Free DNA and Matched... [Video]](https://cancerrecoverygiving.com/wp-content/uploads/2024/07/mp_350048_0_0jpg.jpg)
![Guiding Light: End Of Life Care For Head and Neck Cancer Patients [Video]](https://cancerrecoverygiving.com/wp-content/uploads/2024/07/mp_350009_0_0jpg.jpg)
![Boosting HPV Vaccination: Expert Tips from the Frontline [Video]](https://cancerrecoverygiving.com/wp-content/uploads/2024/06/mp_348134_0_0jpg.jpg)
![Behind the Breakthroughs | Closing the Gap: Equity in Clinical Trials, Research and Patient Care [Video]](https://cancerrecoverygiving.com/wp-content/uploads/2024/07/mp_349877_0_0jpg.jpg)
